|
2012-04-02 |
Sublingual immunotherapy with VALERGEN-Asthma-Children-Phase II |
BIOCEN |
Registered |
|
2012-04-11 |
SURFACEN in ARDS Adults. Phase II |
CENSA |
Registered |
|
2012-04-13 |
Combined Subcutaneous immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II |
BIOCEN |
Registered |
|
2012-05-25 |
Academic trial of sertraline in depression |
DALHOUSIE |
Registered |
|
2012-05-25 |
Podal Reflex Laserpuncture as a treatment for Chronic Adenoiditis - Phase III |
CEADEN |
Registered |
|
2012-06-08 |
HeberPAG® in Mycosis Fungoides (MYFIC Study) |
CIGB |
Registered |
|
2012-06-09 |
Multimodal anesthesia for beating heart surgery |
HHA |
Registered |
|
2012-07-20 |
T1h in severe psoriasis-expanded access program (PUCE) |
CIM |
Registered |
|
2012-07-20 |
Heptavalent Conjugate Vaccine against Pneumococcal in healthy adults (VCN7-T). |
CQB |
Registered |
|
2012-07-20 |
Effectiveness and Safety of Tenofovir + Lamivudine + Efavirenz Generic Scheme for the Treatment of HIV Infection / AIDS in Patients of the CLS,Colombia, 2012-2013. |
CLS |
Registered |
|
2012-09-12 |
Quimi-Hib® and Quimi-Hib(AlPO4) vaccines in an accelerated 6-10-14 weeks primary vaccination series |
CIGB |
Registered |
|
2012-10-12 |
NASVAC Phase II Trial in patients with Chronic Hepatitis B Virus infection |
CIGB |
Registered |
|
2013-01-04 |
D-004 in patients with Bening Prostatic Hyperplasia |
CPN |
Registered |
|
2013-01-04 |
Subcutaneous immunotherapy with PROLINEM -Asthma- Adults-Fase I |
BIOCEN |
Registered |
|
2013-01-17 |
Intravenous CIGB-128-A in patients with brain tumors (BRATINC Study) |
CIGB |
Registered |
|
2013-01-18 |
Safety and Pharmacology of CIGB-300 in cervical cancer (CERVIFARM-300 Study) |
CIGB |
Registered |
|
2013-01-18 |
Biodistribution of CIGB-300 in cervical cancer (CERVIFARM-300-II Study) |
CIGB |
Registered |
|
2013-01-30 |
Safety with interferon in skin carcinomas (SCIENCE study) |
CIGB |
Registered |
|
2013-02-01 |
Squamous cell carcinoma interferons (CECIN study) |
CIGB |
Registered |
|
2013-02-01 |
Nimotuzumab in tumors of head and neck .Phase IV |
CIMAB |
Registered |
